I liked this AGM
Personally, I liked the presentation. Bio sold it short despite getting answers to the questions he so frequently complains about not getting.
Patient 7, is getting the bigger 10-plug pouch which is still in manufacturing and still requires FDA approval for use in patient 7. There's your status update, now stop asking
Conformal Coating - they are still working on the characterization study and other preclinical work. Preclinically the technology is showing efficacy. They still need to develop the gcmp manufacturing procedures and need to develop a way to scale up the tech for use in the cell pouch. Theres your update, now stop asking
Thyroid - currently developing the regulatory packages for submission to the FDA. Expected to be completed this year meaning hopes for a trial in 2023. Again, stop asking
Hemophilia - working with collaborators to continue preclinical studies and development of regulatory package. Intended EU-based clinical trial. Likely 2 years out. There ya have it
TSX Uplisting - you could tell he couldn't answer that question because he wasn't allowed. Basically said they've done everything and it is out of their hands. If you take a look at all of the last tsx uplistings, the announcement came from the company 1-2 days prior to the actual uplisting. Not 2 weeks prior or anything like that. So don't expect any news on it until its actually happening the next day. Also said expect more in the very near term
Business Deals - the intent is to transition existing collaborations into formal agreements. He explicitly mentioned that there is a company out there very interested in the technology for a rare disease indication.
This should all shut bio up for quite a while because this was an extremely transparent presentation. You've complained about not getting answers now you have them whether you like the answer or not